According to the reports of leading pharmaceutical company, Abbott Laboratories, Jameel Shaikh is a Pakistani Origin Scientist who promoted Coronavirus aka COVID-19 ‘5-minute’ testing kit for the Coronavirus aka COVID-19 suspected patients. Jameel Shaikh is legit the only one behind the creation of Abbotts’ Coronavirus 5-minute detective kit in which positive result is given in as little as 5 minutes and negative results in maximum 13 minutes. As per the reports, Jameel Shaikh is the scientist and microbiologist hailing from Pakistan’s southern region from Sindh’s Larkana District. Jameel Shaikh moved to the US –United States after completing his graduation from Karachi’s NED University of Engineering and Technology.
According to the research company, Abbott -5-minute Coronavirus kit will run on the company’s ID NOW platform that is small, light in weight of portable toaster sized kit with 6.6 lbs. and basically works on molecular technology. The main purpose of the development of this Abbott -5-minute is to provide rapid results in the field of health care settings and environments such as physicians, offices, care clinics, and hospital emergency departments. This is going to be a game-changer in the field of public health because the kits that are already in use take 6 hours to detect the results.
Jameel Shaikh is currently and permanently based in San Diego, California also he is an active member of the World Sindhi Congress and the Sindhi Association of North America. After this huge success of this kit invention, the maker of the kit, Jameel Shaikh, aims to deliver 50,000 ID NOW tests per day to the US –United States healthcare system. This kit will save thousands of lives with a timely diagnosis and will also ramp-up the testing capacity of the world’s largest economy.
The Chairman and Chief Operating Officer of Abbott, Robert B. Forb comprehended, “The COVID-19 pandemic will be fought on multiple platforms and fronts, and a portable molecular test that offers results in minutes add to the broad range of diagnostic solutions needed to combat the situation of this virus.” Also, “With the rapid testing on ID NOW, healthcare providers can perform molecular point of care testing outside the traditional four walls of a hospital in eruption hotspots.”
Abbott will make ID NOW COVID-19 tests available from next week to healthcare providers in urgent emergency care settings in the US –United Stated where the majority ID NOW instruments are used nowadays.
https://www.instagram.com/p/B-cO26UDKPt/?fbclid=IwAR30La1mtWcRISVLf0K8T89WTvJ89y72YtzrZT6Pkf2CZ3Sp8nYqSYu57Sk
